DSG2 and type 1 diabetes mellitus: To further examine a protective role for DSG2 in β-cell function, we challenged the mice with streptozotocin (STZ), an alkylating agent that targets the insulin-producing β-cells in the pancreas, thus mimicking β-cell loss and hyperglycemia characteristic of type 1 diabetes [44, 45].